Posts Tagged gsk

Magazine Reveals Drug Companies’ Influence to Engineer Fake Swine Flu Pandemic

by Dr. Mercola

When the swine flu first emerged, World Health Organization officials estimated that between 2 and 7.4 million could die. The panic that ensued mounted worldwide vaccination programs while government agencies prepared for disaster.

But as the world now knows, swine flu was actually relatively harmless … and the deadly “pandemic” never emerged. As it turns out, those who suspected a greed- and money-driven conspiracy was at play may have been right all along.

As the German magazine Der Spiegel reports, the swine flu pandemic of 2009 may have been engineered by the drug companies:

“In mid-May, about three weeks before the swine flu was declared a pandemic, 30 senior representatives of pharmaceutical companies met with WHO Director-General Chan and United Nations Secretary General Ban Ki Moon at WHO headquarters. Read the rest of this entry »

Tags: , , , , , , , , , , , , , , ,

WHO Advisor Secretly Pads Pockets with Big Pharma Money

Posted by Dr. Mercola

healthcare corruption greedA Finnish member of the World Health Organization board, an advisor on vaccines, has received 6 million Euros for his research center from the vaccine manufacturer GlaxoSmithKline.

Although WHO promises transparency, this conflict of interest is not available for the public to see at WHO’s homepage.

Professor Juhani Eskola is the director of the Finnish research vaccine program and a new member of the WHO group ‘Strategic Advisory Group of Experts’ (SAGE). Read the rest of this entry »

Tags: , , , , , , , , ,

“We Expect to Kill Some People With Every Mass Vaccination Campaign”

Read the Label.

Read the Label.

http://www.healthzone.ca/health/newsfeatures/swineflu/article/728601–batch-of-h1n1-vaccine-recalled-for-severe-reactions

A GSK spokesperson admitted, straight up, that they expect people to have severe reactions and some to die from every mass vaccination campaign. They expect it.

How does it feel to head to work every morning, fully knowing that what you do it going to kill someone, put people in wheel chairs and ruin lives? Does that make you feel good? It would make me physically sick. Read the rest of this entry »

Tags: , , , , , , , , , , , , ,

Pharm Giant Kills 12 Argentine Babies in Vaccine Trials

By, Trading Markets on Thursday, July 10, 2008; Posted: 05:23 PM

Buenos Aires, Jul 10, 2008

At least 12 babies who were part of a clinical study to test the effectiveness of a vaccine against pneumonia have died over the past year in Argentina, the local press reported Thursday.

The study was sponsored by global drug giant GlaxoSmithKline and uses children from poor families, who are “pressured and forced into signing consent forms,” the Argentine Federation of Health Professionals, or Fesprosa, said.

“This occurs without any type of state control” and “does not comply with minimum ethical requirements,” Fesprosa said.

The vaccine trial is still ongoing despite the denunciations, and those in charge of the study were cited by the Critica newspaper as saying that the procedures are being carried out in a lawful manner. Read the rest of this entry »

Tags: , , , , , , , , , , , , , , , ,

GSK Faces US Delay on Cancer Vaccine

By Andrew Jack in London, FT.com July 1 2008 03:00

GlaxoSmithKline, the UK-based pharmaceutical company, is unlikely to receive US approval for its key cervical cancer vaccine until 2010 at the earliest, under a new timetable it released yesterday.

After requests for fresh information on Cervarix from the Food & Drug Administration in December, GSK said it had decided to await completion of a pivotal clinical trial to be filed with the US regulator during the first half of next year.

Cervarix is a probable blockbuster treatment that is central to the company’s future growth. The cervical cancer vaccine market is expected to be worth more than $1bn a year in sales.

GSK’s timetable change confirms long-standing analysts’ fears of delays for Cervarix, which is competing with a rival vaccine, Gardasil, produced by Merck of the US and already on sale in north America.

GSK filed originally for US approval from the FDA in March 2007, and it has refused to reveal the regulator’s precise concerns other than to say they relate to “safety and efficacy”.

Observers believe the queries focus on the nature of Cervarix’s proprietary adjuvant, a chemical that boosts the immune response to the vaccine. The FDA has not approved a new adjuvant since the 1930s. Read the rest of this entry »

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,